Biosensor-based assay of exosome biomarker for early diagnosis of cancer Ying DengZhaowei SunGenxi Li Review Open access 27 September 2021 Pages: 157 - 175
Paternal environmental exposure-induced spermatozoal small noncoding RNA alteration meditates the intergenerational epigenetic inheritance of multiple diseases Xin YinAzhar AnwarChenyu Zhang Review Open access 13 September 2021 Pages: 176 - 184
SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic Yiming ShaoYingqi WuXinxin Zhang Review 28 February 2022 Pages: 185 - 195
SARS-CoV-2 variants, immune escape, and countermeasures Yi ZhangHaocheng ZhangWenhong Zhang Review 06 March 2022 Pages: 196 - 207
Multi-target combinatory strategy to overcome tumor immune escape Yingyan Yu Review 04 April 2022 Pages: 208 - 215
Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis Shoubin ZhanPing YangYanbo Wang Research Article 13 April 2022 Pages: 216 - 226
Cannabidiol prevents depressive-like behaviors through the modulation of neural stem cell differentiation Ming HouSuji WangChao Yan Research Article 25 February 2022 Pages: 227 - 239
Accurate quantification of 3′-terminal 2′-O-methylated small RNAs by utilizing oxidative deep sequencing and stem-loop RT-qPCR Yan KongHuanhuan HuXi Chen Research Article 13 April 2022 Pages: 240 - 250
PathogenTrack and Yeskit: tools for identifying intracellular pathogens from single-cell RNA-sequencing datasets as illustrated by application to COVID-19 Wei ZhangXiaoguang XuYun Tan Research Article 22 February 2022 Pages: 251 - 262
Integrated analysis of gut microbiome and host immune responses in COVID-19 Xiaoguang XuWei ZhangSaijuan Chen Research Article 08 March 2022 Pages: 263 - 275
Chemotherapy initiation with single-course methotrexate alone or combined with dactinomycin versus multi-course methotrexate for low-risk gestational trophoblastic neoplasia: a multi-centric randomized clinical trial Lili ChenLing XiWeiguo Lu Research Article 28 June 2021 Pages: 276 - 284
Phase I study of CBM.CD19 chimeric antigen receptor T cell in the treatment of refractory diffuse large B-cell lymphoma in Chinese patients Lei FanLi WangJianyong Li Research Article 02 November 2021 Pages: 285 - 294
FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population Haoran WeiMingming ZhaoDao Wen Wang Research Article 22 June 2021 Pages: 295 - 305